Co-Diagnostics seeks FDA clearance for COVID-19 Test and diagnostic instrument
Co-Diagnostics, Inc. (Nasdaq: CODX), a pioneering molecular diagnostics company, has reached a pivotal milestone by completing its first U.S. Food and Drug Administration (FDA) application ... Read More
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa Biotech, a California-based point-of-care molecular diagnostic company, ... Read More